- Home
- EVAX vs LGCB Comparison
EVAX vs LGCB Comparison
Compare EVAX & LGCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVAX
- LGCB
- Stock Information
- Founded
- EVAX 2008
- LGCB 2011
- Country
- EVAX Denmark
- LGCB Japan
- Employees
- EVAX N/A
- LGCB N/A
- Industry
- EVAX Biotechnology: Biological Products (No Diagnostic Substances)
- LGCB
- Sector
- EVAX Health Care
- LGCB
- Exchange
- EVAX Nasdaq
- LGCB Nasdaq
- Market Cap
- EVAX 16.3M
- LGCB 8.4M
- IPO Year
- EVAX 2021
- LGCB 2023
- Fundamental
- Price
- EVAX $1.79
- LGCB $0.23
- Analyst Decision
- EVAX Strong Buy
- LGCB
- Analyst Count
- EVAX 3
- LGCB 0
- Target Price
- EVAX $33.33
- LGCB N/A
- AVG Volume (30 Days)
- EVAX 211.9K
- LGCB 341.1K
- Earning Date
- EVAX 03-26-2025
- LGCB 03-25-2025
- Dividend Yield
- EVAX N/A
- LGCB N/A
- EPS Growth
- EVAX N/A
- LGCB N/A
- EPS
- EVAX N/A
- LGCB N/A
- Revenue
- EVAX $3,295,000.00
- LGCB $10,289,681.00
- Revenue This Year
- EVAX $9,039.73
- LGCB N/A
- Revenue Next Year
- EVAX $1.47
- LGCB N/A
- P/E Ratio
- EVAX N/A
- LGCB N/A
- Revenue Growth
- EVAX N/A
- LGCB N/A
- 52 Week Low
- EVAX $1.70
- LGCB $0.17
- 52 Week High
- EVAX $22.05
- LGCB $5.71
- Technical
- Relative Strength Index (RSI)
- EVAX 35.07
- LGCB 40.81
- Support Level
- EVAX $1.75
- LGCB $0.22
- Resistance Level
- EVAX $1.99
- LGCB $0.25
- Average True Range (ATR)
- EVAX 0.17
- LGCB 0.03
- MACD
- EVAX 0.05
- LGCB -0.00
- Stochastic Oscillator
- EVAX 10.70
- LGCB 9.23
About EVAX Evaxion Biotech
Evaxion Biotech AS is a clinical-stage biotech company that aspires to the exploration of artificial intelligence, or AI, to develop immunotherapies with improved efficacy when compared to currently marketed products for patients with unmet medical needs. Its pipeline programs are derived from its proprietary AI platforms, PIONEER, EDEN, RAVEN, and ObsERV. The company is utilizing these AI platforms to build a drug development pipeline. Its product candidates are; EVX-01 and EVX-02, for the treatment of various cancers, and the third candidate is cancer immunotherapy, EVX-03, for the treatment of various cancers including non-small-cell-lung-cancer, or NSCLC, is in pre-clinical development.
About LGCB Linkage Global Inc
Linkage Global Inc is a cross-border e-commerce integrated service provider. It provides international e-commerce merchants, overseas brands, import and export trading enterprises, etc. with a globally selected supply chain, digital marketing, e-commerce training, international store, ERP and e-commerce software, social e-commerce and other e-commerce integrated services. The Company has two operating segments: Extend from Japan, and Other Subsidiaries from Hong Kong. The company is Committed to building a one-stop cross-border integrated service platform to make cross-border trade easier. Company operates in Japan, Hong Kong and China, with maximum revenue from Japan.